Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.352 Q1 | 159 | 153 | 228 | 23080 | 2537 | 227 | 10.75 | 150.85 | 38.58 | |
2 | Cancer and Metastasis Reviews | journal | 1.796 Q1 | 167 | 73 | 209 | 10721 | 1853 | 197 | 8.47 | 146.86 | 48.95 | |
3 | Advances in Biological Regulation | journal | 1.534 Q1 | 69 | 36 | 141 | 3689 | 808 | 134 | 5.95 | 102.47 | 48.94 | |
4 | Tumour Virus Research | journal | 1.146 Q2 | 34 | 14 | 116 | 1387 | 534 | 109 | 4.62 | 99.07 | 45.68 | |
5 | Differentiation | journal | 1.069 Q2 | 107 | 23 | 121 | 2191 | 429 | 117 | 3.04 | 95.26 | 29.35 | |
6 | Nature Reviews Cancer | journal | 16.955 Q1 | 505 | 105 | 337 | 9854 | 9592 | 186 | 27.84 | 93.85 | 35.96 | |
7 | NAR Cancer | journal | 17 | 53 | 37 | 4464 | 180 | 36 | 4.86 | 84.23 | 44.76 | ||
8 | Cancers | journal | 1.349 Q2 | 133 | 6342 | 6394 | 515698 | 42531 | 6261 | 6.47 | 81.31 | 44.90 | |
9 | Molecular Cancer | journal | 6.896 Q1 | 196 | 162 | 477 | 12537 | 15669 | 446 | 35.77 | 77.39 | 41.54 | |
10 | Journal of Hematology and Oncology | journal | 4.241 Q1 | 144 | 199 | 433 | 15362 | 8406 | 425 | 19.97 | 77.20 | 41.33 | |
11 | Signal Transduction and Targeted Therapy | journal | 5.157 Q1 | 117 | 425 | 384 | 31800 | 7038 | 249 | 17.80 | 74.82 | 41.75 | |
12 | International Journal of Oncology | journal | 1.105 Q2 | 139 | 139 | 926 | 10354 | 5305 | 926 | 5.61 | 74.49 | 37.95 | |
13 | Apoptosis : an international journal on programmed cell death | journal | 1.017 Q2 | 128 | 51 | 202 | 3663 | 977 | 191 | 4.95 | 71.82 | 47.04 | |
14 | Angiogenesis | journal | 1.056 Q2 | 101 | 57 | 155 | 3881 | 1298 | 150 | 8.65 | 68.09 | 39.30 | |
15 | Cellular oncology (Dordrecht) | journal | 1.326 Q2 | 58 | 89 | 194 | 6059 | 1305 | 189 | 6.84 | 68.08 | 45.78 | |
16 | Cancer Letters | journal | 1.923 Q1 | 216 | 476 | 1352 | 32194 | 12422 | 1340 | 8.98 | 67.63 | 41.74 | |
17 | Cancer Genomics and Proteomics | journal | 0.748 Q3 | 50 | 61 | 176 | 4044 | 738 | 176 | 3.50 | 66.30 | 35.16 | |
18 | Oncology Reviews | journal | 0.737 Q3 | 31 | 12 | 70 | 793 | 295 | 69 | 3.94 | 66.08 | 51.92 | |
19 | Journal of Experimental and Clinical Cancer Research | journal | 2.350 Q1 | 120 | 361 | 978 | 23361 | 11402 | 977 | 11.40 | 64.71 | 42.77 | |
20 | Cancer Communications | journal | 2.357 Q1 | 79 | 105 | 229 | 6574 | 2159 | 180 | 9.45 | 62.61 | 39.61 | |
21 | Clinical and Experimental Metastasis | journal | 1.108 Q2 | 109 | 49 | 180 | 2969 | 829 | 167 | 4.13 | 60.59 | 41.81 | |
22 | Endocrine-Related Cancer | journal | 1.416 Q2 | 146 | 106 | 361 | 6383 | 2149 | 345 | 6.05 | 60.22 | 48.13 | |
23 | Molecular Therapy - Oncolytics | journal | 1.530 Q1 | 42 | 181 | 268 | 10874 | 1713 | 268 | 6.14 | 60.08 | 40.29 | |
24 | Experimental Hematology and Oncology | journal | 1.301 Q2 | 42 | 58 | 101 | 3483 | 670 | 100 | 7.16 | 60.05 | 39.63 | |
25 | Cancer Treatment and Research | journal | 65 | 31 | 110 | 1856 | 308 | 0 | 3.04 | 59.87 | 50.00 | ||
26 | Molecular Oncology | journal | 1.773 Q1 | 113 | 224 | 515 | 13171 | 3834 | 505 | 7.32 | 58.80 | 45.17 | |
27 | Discover Oncology | journal | 44 | 63 | 85 | 3669 | 376 | 83 | 4.59 | 58.24 | 42.64 | ||
28 | Epigenomics | journal | 0.894 Q2 | 77 | 141 | 403 | 7994 | 1725 | 380 | 3.95 | 56.70 | 49.89 | |
29 | Cancer Gene Therapy | journal | 1.207 Q2 | 99 | 98 | 163 | 5506 | 852 | 155 | 5.37 | 56.18 | 45.13 | |
30 | Cancer Cell International | journal | 1.099 Q2 | 80 | 668 | 1113 | 36277 | 6711 | 1113 | 6.11 | 54.31 | 41.46 | |
31 | Frontiers in Oncology | journal | 1.291 Q2 | 136 | 5851 | 4942 | 315606 | 29148 | 4841 | 5.47 | 53.94 | 42.09 | |
32 | Cell Stress | journal | 1.517 Q1 | 27 | 22 | 123 | 1172 | 662 | 123 | 6.83 | 53.27 | 44.44 | |
33 | Oncology Reports | journal | 0.812 Q3 | 115 | 345 | 1700 | 18205 | 7105 | 1700 | 3.92 | 52.77 | 38.90 | |
34 | Oncogene | journal | 2.360 Q1 | 370 | 517 | 1451 | 26916 | 12964 | 1441 | 8.00 | 52.06 | 40.98 | |
35 | Virus Research | journal | 1.154 Q2 | 144 | 279 | 746 | 14221 | 4040 | 738 | 6.34 | 50.97 | 42.80 | |
36 | FASEB BioAdvances | journal | 0.713 Q3 | 18 | 91 | 118 | 4595 | 335 | 113 | 2.84 | 50.49 | 40.71 | |
37 | Infectious Agents and Cancer | journal | 0.837 Q3 | 47 | 69 | 160 | 3477 | 544 | 159 | 3.22 | 50.39 | 46.92 | |
38 | npj Precision Oncology | journal | 36 | 100 | 93 | 5004 | 1011 | 92 | 9.82 | 50.04 | 39.16 | ||
39 | Cell Death and Disease | journal | 2.099 Q1 | 164 | 1101 | 3054 | 54830 | 28044 | 2993 | 8.83 | 49.80 | 42.63 | |
40 | British Journal of Cancer | journal | 2.272 Q1 | 272 | 461 | 1166 | 22279 | 8883 | 1031 | 7.66 | 48.33 | 44.14 | |
41 | Carcinogenesis | journal | 1.178 Q2 | 223 | 156 | 490 | 7432 | 2375 | 471 | 4.25 | 47.64 | 38.61 | |
42 | Oncology Letters | journal | 0.639 Q3 | 81 | 815 | 4913 | 38294 | 15170 | 4913 | 3.03 | 46.99 | 38.77 | |
43 | Molecular Medicine Reports | journal | 0.650 Q3 | 86 | 812 | 3729 | 38045 | 12771 | 3729 | 3.38 | 46.85 | 43.12 | |
44 | Cell Death Discovery | journal | 1.399 Q2 | 58 | 368 | 350 | 17084 | 2117 | 333 | 6.67 | 46.42 | 41.47 | |
45 | Breast Cancer Research | journal | 2.225 Q1 | 175 | 111 | 434 | 5041 | 3312 | 428 | 7.90 | 45.41 | 51.12 | |
46 | Future Oncology | journal | 0.836 Q3 | 90 | 441 | 1030 | 19469 | 3421 | 960 | 3.34 | 44.15 | 38.20 | |
47 | Cancer Treatment and Research Communications | journal | 0.520 Q3 | 23 | 227 | 161 | 9840 | 314 | 151 | 2.07 | 43.35 | 41.91 | |
48 | Journal for ImmunoTherapy of Cancer | journal | 3.450 Q1 | 117 | 551 | 994 | 23687 | 12239 | 988 | 10.91 | 42.99 | 42.42 | |
49 | Cancer Epidemiology | journal | 0.957 Q2 | 86 | 139 | 481 | 5939 | 1415 | 459 | 2.78 | 42.73 | 51.81 | |
50 | Targeted Oncology | journal | 1.233 Q2 | 59 | 67 | 218 | 2758 | 1001 | 212 | 4.73 | 41.16 | 41.83 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®